Thor Industries beat FactSet's expectations but missed Zacks bottom-line estimates.
Conditions seem ripe for continued upward momentum in stocks, as long as the Federal Reserve or unexpected shocks don't get in the way.
The cardiac device company's shares dipped more than 20% on news of the transaction, which could be worth up to $860 million.
Trade-Ideas LLC identified Thoratec (THOR) as a pre-market mover with heavy volume candidate
With Thoratec Corp. (THOR) off the market following its recent purchase by St. Jude Medical Inc. (STJ), M&A activity may start to circulate in the heart care device sector.